Ukrainian president Volodymyr Zelensky’s obvious impatience over Nato’s slow-moving decision-making process has reportedly irritated US officials enough that they reconsidered Ukraine’s invitation to join the alliance. For months, Mr Zelensky has appealed to Nato leaders hoping they would accept his country’s application to join the alliance as they fight off Russian troops. But Nato countries have been reluctant – not wanting to rock the boat too much with Russia during the middle of the war. Then, after Nato countries failed to deliver a specific timeline to Mr Zelensky on Nato membership before the summit this week, Mr Zelensky’s frustration resulted in a more aggressive approach in the form of a tweet. “It’s unprecedented and absurd when time frame is not set neither for the invitation nor for Ukraine’s membership. While at the same time vague wording about "conditions" is added even for inviting Ukraine. It seems there is no readiness neither to invite Ukraine to NATO nor to make it a member of the Alliance,” Mr Zelensky wrote on Tuesday. “This means that a window of opportunity is being left to bargain Ukraine’s membership in NATO in negotiations with Russia. And for Russia, this means motivation to continue its terror.” He added: “Uncertainty is weakness. And I will openly discuss this at the summit.” Mr Zelensky’s strong message was a clear response to Nato’s unspecific and vague statement regarding Ukraine’s membership: “We will be in a position to extend an invitation to Ukraine when allies agree and conditions are met” However the Ukrainian’s message to Nato leaders left US officials feeling particularly “furious”, a source familiar with the situation told The Washington Post. Several US officials allegedly questioned whether the alliance should get rid of the passage which Mr Zelensky found “absurd”, The Post reported. The US has already given Ukraine more than $75bn in assistance. Most recently the Pentagon announced that they had sent the controversial cluster munitions to assist in Ukraine’s fight against Russia. Despite the hiccup, byy the end of the Nato summit on Wednesday, Mr Zelesnky had come to Nato’s accept decision calling it a “significant security victory” while still reiterating the preferred outcome would be an invitation to join Nato. Read More Pentagon says cluster munitions have arrived in Ukraine The Nato summit was not the triumph that Zelensky hoped it would be Nato could have sent a stronger signal on Ukraine’s future – Iain Duncan Smith Pentagon says cluster munitions have arrived in Ukraine Senators renew effort to bar future US withdrawal from Nato Republican senator should drop his 'irresponsible' protest and OK military nominees, Biden says

The Trump ally postpones plans for another vote as holdouts to his bid for the speakership dig in.

America’s employers pulled back on hiring but still delivered another month of solid gains in June, adding 209,000 jobs, a sign that the economy’s resilience is confounding the Federal Reserve’s drive to slow growth and inflation

The generational shift at quarterback in the NFL reached a new milestone last week

By David Stanway SINGAPORE The target of keeping long-term global warming within 1.5 degrees Celsius (2.7 Fahrenheit) is

A U.S. appeals court has halted a lower court ruling that would have shut down southeast Alaska’s Chinook salmon troll fishery for the summer to protect endangered orca whales that eat the fish

Oscar-winning actor Susan Sarandon and “Scream” star Melissa Barrera were each dropped by Hollywood companies after making comments on the Israel-Hamas war that some deemed antisemitic

Russian President Vladimir Putin accepted an invitation from Kim Jong Un to visit North Korea after the two

CAMARILLO, Calif.--(BUSINESS WIRE)--Jun 29, 2023--

The Buffalo Bills are taking it slowly with safety Damar Hamlin, who is being held back from participating in the team’s first few days of voluntary practices some five months after having a near-death experience on the field

One of the scientists whose work pioneered the development of medications such as Ozempic and Wegovy has revealed why life may become “so miserably boring” after two years of using the drug. Ozempic is an FDA-approved medication used for the treatment of type 2 diabetes. It works by mimicking a hormone called glucagon-like peptide 1 (GLP-1), which regulates blood sugar levels and slows down the rate at which food leaves the stomach, often creating the feeling of fullness. These semaglutide injections – sold under the brand names Ozempic and Wegovy – have soared in popularity as many people, including Hollywood celebrities, have used it for weight loss. What’s more, people have also found Ozempic has been effective in curing their addictive habits, like drinking, smoking, shopping, or nail biting. However, because of Ozempic’s increasing popularity, it has led to national shortages of the type 2 diabetes treatment – leaving those who actually need it without. In an interview with Wired, professor Jens Juul Holst – who received the Warren Alpert Foundation Prize in 2021 for his work developing treatments based on the GLP-1 hormone – spoke about the effects of Ozempic, and why he believes many people will stop taking the medication after just a few years. “What happens is that you lose your appetite and also the pleasure of eating, and so I think there’s a price to be paid when you do that,” Holst told Wired. “If you like food, then that pleasure is gone. The craving for food for some people is taken away when they take GLP-1 drugs.” He continued: “That may eventually be a problem, that once you’ve been on this for a year or two, life is so miserably boring that you can’t stand it any longer and you have to go back to your old life.” Holst added that medications like Ozempic and Wegovy have been on the market since 2005, though studies show that these people don’t stay on them for very long. “It’s just like every other drug, they don’t stay on it for many reasons,” he explained. “One of the reasons, as I said, is that once you have tried it and you realise you’ve lost interest in food, then that may be enough.” “We don’t know why people stop taking these drugs, but we know for a fact that they do stop. They do that all over the world.” A 2020 study found that 70 per cent of people who took GLP-1 drugs for type 2 diabetes stopped taking them within two years. However, this could pose a problem for many patients taking semaglutide injections. Research has found that people who stopped taking Ozempic or Wegovy for weight loss experienced weight rebound. A trial published in April 2022 saw participants gain back two thirds of the weight they had lost after 68 weeks of taking semaglutide. As for celebrities who use the once-weekly injection for weight loss, despite not having diabetes or clinical obesity, Hans instead called attention to the “many terrible problems” that those with diabetes have struggled with by not having drugs like Ozempic readily available. “Have you ever visited a diabetes hospital? It’s really deplorable,” he said. “People come in with amputated limbs and compromised cognitive functions and heart problems or they can barely move – they’re miserable and depressed. It’s really serious. There is so much you can improve with a drug that is not only a weight-loss drug but is also an anti-diabetic.” Amidst the popularity of semaglutide injections, the US Food and Drug Administration has issued warnings for consumers not to use off-brand versions of Ozempic or Wegovy, because they may not include the same GLP-1 hormone used in approved medications. Earlier this month, agency officials reported problems with patients using compounded versions of semaglutide – which combines traditional semaglutide with other ingredients. These drugs are not FDA-approved, and the agency does not verify the safety or effectiveness of compounded drugs. Consumers should only use drugs containing semaglutide with a prescription from a licensed health care provider and obtained from a state-licensed pharmacy or other facilities registered with the FDA, the agency said. Read More What is ‘Ozempic face’? Doctors warn about facial ageing side effect of diabetes medications How does Wegovy work? The ‘game changing’ weight loss drug beloved by Hollywood FDA warns against using off-brand versions of Ozempic, Wegovy for weight loss Scientist behind Ozempic says drug can make life ‘so miserably boring’ Pregnant Stassi Schroeder admits she wants to ‘try’ Ozempic after giving birth Doctors warn about ‘Ozempic face’ side effect of medications

Shohei Ohtani’s agent says the Los Angeles Angels’ two-way superstar is determined to continue his career as both a pitcher and a hitter after he recovers from his latest elbow injury